AVF Stenosis by Electronic Stethoscope
Detection and Prediction of the Stenosis of Arteriovenous Fistula in Hemodialysis Patients by an Electronic Stethoscope
2 other identifiers
observational
30
1 country
1
Brief Summary
The prevalence rate of hemodialysis in Taiwan is the highest in the world, and the number of new cases of hemodialysis and the death rate are gradually increasing every year. Long-term hemodialysis patients must receive dialysis through the arteriovenous fistula. If the arteriovenous fistula is narrowed, the dialysis effect will be poor or the dialysis will not be possible due to blockage, resulting in complications and mortality. The detection of the arteriovenous fistula must rely on the assistance of professionals. \* Is it easier for clinicians to detect arteriovenous fistula stenosis by an electronic stethoscope? This study uses an electronic stethoscope to take the hemodialysis center of Douliu District, Yunlin Branch of National Taiwan University Hospital as the experimental site. Select 30 patients who need long-term dialysis, adults (20-99 years old) who have been on dialysis for more than 3 months and have arteriovenous fistula. The experiment period lasted for 3 months, and each person received 2-3 voices per week, about 1080 voices. The main purpose is to use the electronic stethoscope and the experience of traditional professionals, hoping to detect and predict the stenosis in advance. The important key factors of vascular access stenosis in hemodialysis patients were found through regression analysis of the Albumin value and clinical data obtained from routine treatment of patients of a fixed blood test in monthly hemodialysis center.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedFirst Submitted
Initial submission to the registry
February 22, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedFebruary 27, 2026
March 1, 2023
3 months
February 22, 2026
February 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
AVF stenosis
Clinical stenosis: Diagnosed by attending nephrologist based on physical examination abnormalities (high-pitched bruit, pulsatile flow, diminished thrill) - Confirmed by Doppler ultrasound showing \>50% diameter reduction - Intervention: Percutaneous transluminal angioplasty (PTA)
From enrollment to the end of study at 3 months
Secondary Outcomes (1)
Abnormal AVF sound threshold
From enrollment to the end of study at 3 months
Interventions
The detection of the arteriovenous fistula must rely on the assistance of professionals by palpation or a conventional stethoscope. This study will investigate the detection and prediction of arteriovenous fistula stenosis in hemodialysis patients by an electronic stethoscope.
Eligibility Criteria
End stage renal disease patients received hemodialysis for more than 3 months
You may qualify if:
- Age 20-99 years - Chronic hemodialysis ≥3 months - Functional arteriovenous fistula (AVF) - Ability to provide informed consent
You may not qualify if:
- Arteriovenous graft (AVG) - Central venous catheter (Permcath) - Vulnerable populations unable to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital Yunlin Branch
Douliu, Taiwan, 640, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2026
First Posted
February 27, 2026
Study Start
March 17, 2023
Primary Completion
June 16, 2023
Study Completion
September 30, 2023
Last Updated
February 27, 2026
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share